Stocks and Investing Stocks and Investing
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023
Thu, July 6, 2023
Wed, July 5, 2023

Robert Burns Reiterated (VIRX) at Strong Buy with Decreased Target to $10 on, Jul 5th, 2023


Published on 2024-10-28 04:38:42 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "Viracta Therapeutics, Inc." (VIRX) at Strong Buy with Decreased Target from $33 to $10 on, Jul 5th, 2023.

Robert has made no other calls on VIRX in the last 4 months.



There are 3 other peers that have a rating on VIRX. Out of the 3 peers that are also analyzing VIRX, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $7 on, Tuesday, May 9th, 2023
  • Andrew Berens of "SVB Securities" Maintained at Buy and Held Target at $11 on, Monday, May 8th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Monday, March 27th, 2023